Funding search · EIN 954296919 · Studio City, CA

International Myeloma Foundation

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

14
grants reported
$410,000
total given
2021–2024
filing years
$30,000
median grant

Based on grants this organization reported to the IRS for tax years 20212024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Funder website ↗Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

Grant history

All 14 reported grants, largest first.

  • $53,333

    New York Weill Cornell Medical Center Fund · New York, NY · 2023

    Characterizing the role and targeting of the histone methyltransferase setd2 in multiple myeloma.

  • $53,333

    Case Western Reserve University · Cleveland, OH · 2022

    Novel adjuvants to proteasome inhibitors for myeloma therapy

  • $33,333

    National Cancer Institute · New York, NY · 2024

    Improving the lives of all people through cancer research

  • $33,333

    The General Hospital Corporation · Boston, MA · 2023

    Advancing spinal stability in multiple myeloma: a predictive biomechanical simulation approach.

  • $33,333

    Trustees of Boston University · Boston, MA · 2023

    Defining a molecular signature of cardiotoxicity in systemic immunoglobin light chain amyloidosis.

  • $33,333

    Dana Farber Cancer Institute · Boston, MA · 2022

    Defining cell states underlying treatment resistance in myeloma by integrating multiomic sequencing data

  • $33,333

    University of San Diego · San Diego, CA · 2021

    Tuning the innate immune multiple myeloma microenvironment by modulating irf4

  • $26,667

    New York Weill Cornell Medical Center Fund · New York, NY · 2024

    Characterizing the role and targeting of the histone methyltransferase setd2 in multiple myeloma.

  • $26,667

    Case Western Reserve University · Cleveland, OH · 2023

    Deciphering the epigenomic mechanisms of transformation from benign monoclonal gammapathies to symptomatic multiple myeloma.

  • $16,667

    The General Hospital Corporation · Boston, MA · 2024

    Advancing spinal stability in multiple myeloma: a predictive biomechanical simulation approach.

  • $16,667

    Dana Farber Cancer Institute · Boston, MA · 2023

    Tuning the innate immune multiple myeloma microenvironment by modulating irf4

  • $16,667

    Trustees of Boston University · Boston, MA · 2022

    Defining a molecular signature of cardiotoxicity in systemic immunoglobin light chain amyloidosis

  • $16,667

    University of San Diego · San Diego, CA · 2022

    Tuning the innate immune multiple myeloma microenvironment by modulating irf4

  • $16,667

    Dana Farber Cancer Institute · Boston, MA · 2021

    Characterization of rrol-driven lipogenic signaling in multiple myeloma cells.

Who else funds this kind of work

Same state

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.